Edition:
United States

Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

10.25USD
18 Aug 2017
Change (% chg)

$0.20 (+1.99%)
Prev Close
$10.05
Open
$9.95
Day's High
$10.45
Day's Low
$9.95
Volume
158,917
Avg. Vol
118,234
52-wk High
$17.50
52-wk Low
$9.30

SCMP.OQ

Chart for SCMP.OQ

About

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is... (more)

Overall

Beta: 1.46
Market Cap(Mil.): $477.16
Shares Outstanding(Mil.): 46.55
Dividend: --
Yield (%): --

Financials

  SCMP.OQ Industry Sector
P/E (TTM): -- 79.67 32.70
EPS (TTM): -3.30 -- --
ROI: -41.00 2.87 14.88
ROE: -204.07 5.20 16.12

BRIEF-Sucampo reports Q2 GAAP loss per share $3.92

* Q2 earnings per share view $0.27 -- Thomson Reuters I/B/E/S

Aug 02 2017

BRIEF-Sucampo Pharmaceuticals says board voted to increase authorized size of board from six to seven

* Sucampo Pharmaceuticals Inc - On July 15 co's board voted to increase authorized size of board by one, from six to seven Source text: [http://bit.ly/2tgJFdK] Further company coverage:

Jul 19 2017

BRIEF-Sucampo Pharmaceuticals announces issuance of new patent for VTS-270

* Sucampo Pharmaceuticals announces issuance of new patent for VTS-270

Jun 13 2017

BRIEF-Sucampo Pharmaceuticals files for mixed shelf of up to $250 mln

* Sucampo Pharmaceuticals Inc files for mixed shelf of up to $250.0 million - SEC filing Source text - http://bit.ly/2ra1ONz Further company coverage:

Jun 09 2017

BRIEF-Sucampo Pharmaceuticals files for offering of up to 2.8 mln shares of class A common stock by selling stockholders

* Sucampo Pharmaceuticals Inc files for offering of up to 2.8 million shares of co's class a common stock by selling stockholders - sec filing Source text -http://bit.ly/2r3wmfP Further company coverage:

Jun 09 2017

BRIEF-Sucampo Q1 gaap earnings per share $0.10

* Q1 earnings per share view $0.27 -- Thomson Reuters I/B/E/S

May 03 2017

BRIEF-Sucampo reports Q4 EPS $0.34

* Sucampo reports fourth quarter and full year 2016 financial results

Mar 08 2017

Earnings vs. Estimates